← Back to headlines
Lantheus Weighs Potential $7 Billion Sale After Curium's Offer
Lantheus Holdings, a radiopharmaceutical company, is reportedly considering a potential $7 billion sale following an offer from Curium Pharma, according to a Bloomberg News report.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
